HCW Biologics Inc. (HCWB )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol HCWB
- Company HCW Biologics Inc.
- Price $3.06
- Changes Percentage 1.83
- Change 0.055
- Day Low $2.61
- Day High $3.11
- Year High $100.8
- Year Low $2.3
- Market Cap $6,454,821
- Price Avg 50 EMA (D) $3.87
- Price Avg 200 EMA (D) $7.29
- Exchange NASDAQ
- Volume 67,805
- Average Volume 1,888,340
- Open $2.76
- Previous Close $3
- EPS -16.41
- PE -0.18
- Earnings Announcement 2025-11-13 05:00:00
- Shares Outstanding $2,151,607
Company brief: HCW BIOLOGICS INC. (HCWB )
- Healthcare
- Biotechnology
- Dr. Hing C. Wong Ph.D.
- https://www.hcwbiologics.com
- US
- N/A
- 07-20-2021
- US40423R1059
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.